1991
DOI: 10.1007/bf01799625
|View full text |Cite
|
Sign up to set email alerts
|

DNA‐based presymptomatic diagnosis of Wilson disease

Abstract: Investigation using DNA markers in a family with Wilson disease revealed that an apparently normal child of 10 years of age with non-diagnostic copper biochemistry had the disease. The procedure used linked restriction fragment length polymorphic markers. Demonstration of increased liver copper concentration from a liver biopsy confirmed the diagnosis and the child was started on chelation therapy. Two other asymptomatic siblings were shown, using the same techniques, not to have the disease. Similar analysis … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

1995
1995
2020
2020

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…Genetic testing is available at a few research laboratories. 45,46 The biochemical tests used to diagnose WD are shown in Table 3.…”
Section: Geneticsmentioning
confidence: 99%
“…Genetic testing is available at a few research laboratories. 45,46 The biochemical tests used to diagnose WD are shown in Table 3.…”
Section: Geneticsmentioning
confidence: 99%
“…Although this approach has been possible using linked genes, 31 its potential for diagnosis rather than research was realised after the cloning of the gene and the description of multi-allele microsatellite markers. 32 33 Gene tracking can be successfully applied, and is particularly useful in families where a newly diagnosed child has siblings who could be presymptomatic or unaVected.…”
Section: Genetic Investigation: Gene Trackingmentioning
confidence: 99%
“…To address this, the Medical Genetics and Metabolism Department at the National Children's Hospital (HNN) now provides molecular diagnoses for a group of conditions including Wilson disease (OMIM #277900). Molecular testing for early detection was implemented as a strategic measure to reduce morbidity and mortality . The project's goal was to optimize the benefits of molecular testing through extended familial cascade screening, genetic counseling, and reproductive planning…”
Section: Introductionmentioning
confidence: 99%
“…Molecular testing for early detection was implemented as a strategic measure to reduce morbidity and mortality. [12][13][14] The project's goal was to optimize the benefits of molecular testing through extended familial cascade screening, genetic counseling, and reproductive planning. 15 In this study, we characterize the phenotype and genotype of the Costa Rican pediatric population with WD who had molecular testing between 2010 and 2015 and compare the results with a previous report from our center to demonstrate the impact of strategic measures in the delivery of genetics services.…”
mentioning
confidence: 99%